Advent France Biotechnology (AFB), a regulated investment company focused on life sciences, has announced the first close of its second fund at €86m (US$102m). The European Investment Fund (EIF) and…
Advent France Biotechnology (AFB), a regulated investment company focused on life sciences, has announced the first close of its second fund at €86m (US$102m). The European Investment Fund (EIF) and…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


